Evidence map›Paper›PMID 23209549›Full record

ArticlePloS one2012

Disparities in the burden of HIV/AIDS in Canada.

Robert S Hogg, Katherine Heath, Viviane D Lima, Bohdan Nosyk, Steve Kanters, Evan Wood, Thomas Kerr, Julio S G Montaner

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. The impact of drug coverage on viral suppression among people living with HIV in Ontario, Canada.Canadian journal of public health = Revue canadienne de sante publique · 2018
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Robert S HoggBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada ; Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada.
Katherine Heath
Viviane D Lima
Bohdan Nosyk
Steve Kanters
Evan Wood
Thomas Kerr
Julio S G Montaner

Funding

Seek and Treat for Optimal Outcomes and Prevention in HIV & AIDS in IDUDP1DA026182 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MONTANER, JULIO SERGIO GONZALEZ · 2008 to 2013
$3.9M
Modeling different strategies to reduce the public health impact of the HCV/HIV eR03DA033851 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI LIMA, VIVIANE DIAS · 2012 to 2013
$55k
NIDA NIH HHS 1DP1DA026182-01NIDA NIH HHS DP1 DA026182NIDA NIH HHS R03 DA033851
6 · The paper itself

Abstract

backgroundWe aimed to characterize changes in patterns of new HIV diagnoses, HIV-related mortality, and HAART use in Canada from 1995 to 2008.

methodsData on new HIV diagnoses were obtained from Health Canada, HIV-related mortality statistics were obtained from Statistics Canada, and information on the number of people on HAART was obtained from the single antiretroviral distribution site in British Columbia (BC), and the Intercontinental Marketing Services Health for Ontario and Quebec. Trends of new HIV-positive tests were assessed using Spearman rank correlations and the association between the number of individuals on HAART and new HIV diagnoses were estimated using generalized estimating equations (GEE).

resultsA total of 34,502 new HIV diagnoses were observed. Rates of death in BC are higher than those in Ontario and Quebec with the rate being 2.03 versus 1.06 and 1.21 per 100,000 population, respectively. The number of HIV-infected individuals on HAART increased from 2,081 in 1996 to 20,431 in 2008 in the three provinces (nearly 10-fold increase). BC was the only province with a statistically significant decrease (trend test p<0.0001) in the rate of new HIV diagnoses from 18.05 to 7.94 new diagnoses per 100,000 population. Our analysis showed that for each 10% increment in HAART coverage the rate of new HIV diagnoses decreased by 8% (95% CI: 2.4%, 13.3%)

interpretationExcept for British Columbia, the number of new HIV diagnoses per year has remained relatively stable across Canada over the study period. The decline in the rate of new HIV diagnoses per year may be in part attributed to the greater expansion of HAART coverage in this province.

Indexed as

Healthcare DisparitiesAcquired Immunodeficiency SyndromeBritish ColumbiaCanadaHIV InfectionsHumansOntarioQuebec

Identifiers

PMID23209549
PMCPMC3507870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.